Literature DB >> 31139992

Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.

Yan Zhu1, Mei-Dong Xu1, Chen Xu2, Xiao-Cen Zhang1,3, Shi-Yao Chen1, Yun-Shi Zhong1, Yi-Qun Zhang1, Wei-Feng Chen1, Tian-Yin Chen1, Jia-Xin Xu1, Li-Qing Yao1, Quan-Lin Li4, Ping-Hong Zhou5.   

Abstract

BACKGROUND: The endoscopic resection of gastrointestinal mesenchymal tumors (GIMTs) is widely accepted because of its minimal invasiveness. However, one major concern is the high rate of positive microscopic margins remaining following endoscopic resection, which was thought to be related to a higher risk of recurrence. This study aimed to determine whether positive margins affect the recurrence rate of gastric GIMTs and the factors associated with positive margins.
METHODS: Patients with gastric GIMTs were recruited retrospectively from January 2008 to December 2013. Clinical and pathological features, endoscopic procedure information, and follow-up data were collected and analyzed.
RESULTS: The study included 777 patients. All tumors were removed along with the pseudocapsule without macroscopic residual (ER0), and the median tumor size was 15.2 mm (range 3-100 mm). Pathological evaluation revealed 371(47.7%) GISTs. The rate of microscopic R1 resection rate was 47.0% (443/777). In a stepwise multivariate analysis, a significantly increased incidence of R1 resection was recorded for the GISTs (OR 11.13, 95% CI 3.00-41.37). In a subgroup analysis of GISTs, a univariate analysis revealed that EFTR achieved a higher rate of R0 resection (OR 0.56, 95% CI 0.31-1.00), but it was proven insignificant in a stepwise multivariate analysis. Local recurrence occurred in two patients (0.3%) during a mean follow-up time of 34.2 months. Differences in the recurrence rates between the R0 and R1 groups were statistically insignificant (P = 0.841).
CONCLUSIONS: R1 resection for gastric GIMTs is not related to a higher recurrence rate than R0 resection, and ER0 resection is sufficient for gastric GIMTs.

Entities:  

Keywords:  Endoscopic full-thickness resection; Endoscopic submucosal excavation; Gastrointestinal mesenchymal tumor; Gastrointestinal stromal tumor; R0 resection; Submucosal tunnel endoscopic resection

Year:  2019        PMID: 31139992     DOI: 10.1007/s00464-019-06744-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  30 in total

1.  Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.

Authors:  Martin D McCarter; Cristina R Antonescu; Karla V Ballman; Robert G Maki; Peter W T Pisters; George D Demetri; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Linda McCall; David M Ota; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2012-07       Impact factor: 6.113

2.  Safe laparoscopic resection of a gastric gastrointestinal stromal tumor close to the esophagogastric junction.

Authors:  Yasuo Sakamoto; Yoshihisa Sakaguchi; Hisafumi Akimoto; Yoshiki Chinen; Miyako Kojo; Masahiko Sugiyama; Kazutoyo Morita; Hiroshi Saeki; Kazuhito Minami; Yuji Soejima; Yasushi Toh; Takeshi Okamura
Journal:  Surg Today       Date:  2012-01-24       Impact factor: 2.549

3.  Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from the muscularis propria.

Authors:  Ping-Hong Zhou; Li-Qing Yao; Xin-Yu Qin; Ming-Yan Cai; Mei-Dong Xu; Yun-Shi Zhong; Wei-Feng Chen; Yi-Qun Zhang; Wen-Zheng Qin; Jian-Wei Hu; Jing-Zheng Liu
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

4.  Microscopic margins of resection influence primary gastrointestinal stromal tumor survival.

Authors:  Fausto Catena; Monica Di Battista; Luca Ansaloni; Maria Pantaleo; Pietro Fusaroli; Valerio Di Scioscio; Donatella Santini; Margherita Nannini; Maristella Saponara; Giovanni Ponti; Roberto Persiani; Paolo Delrio; Federico Coccolini; Salomone Di Saverio; Guido Biasco; Daniel Lazzareschi; Antonio Pinna
Journal:  Onkologie       Date:  2012-10-16

5.  Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours.

Authors:  C Langer; B Gunawan; P Schüler; W Huber; L Füzesi; H Becker
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

6.  Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Authors:  Haluk R Unalp; Hayrullah Derici; Erdinc Kamer; Ali D Bozdag; Ercument Tarcan; Mehmet A Onal
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

Review 7.  Management of gastrointestinal stromal tumors: from diagnosis to treatment.

Authors:  Pascal Bucher; Peter Villiger; Jean-François Egger; Leo H Buhler; Philippe Morel
Journal:  Swiss Med Wkly       Date:  2004-03-20       Impact factor: 2.193

8.  Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).

Authors:  S Bauer; P Rutkowski; P Hohenberger; R Miceli; E Fumagalli; J A Siedlecki; B-P Nguyen; M Kerst; M Fiore; P Nyckowski; M Hoiczyk; A Cats; P G Casali; J Treckmann; F van Coevorden; A Gronchi
Journal:  Eur J Surg Oncol       Date:  2014-01-15       Impact factor: 4.424

9.  Over-the-scope clip-assisted method for resection of full-thickness submucosal lesions of the gastrointestinal tract.

Authors:  Shabnam Sarker; Juan Pablo Gutierrez; Leona Council; Jason D Brazelton; Kondal R Kyanam Kabir Baig; Klaus Mönkemüller
Journal:  Endoscopy       Date:  2014-05-15       Impact factor: 10.093

Review 10.  Long-Term Outcomes after Endoscopic Treatment of Gastric Gastrointestinal Stromal Tumor.

Authors:  Jong-Jae Park
Journal:  Clin Endosc       Date:  2016-05-19
View more
  1 in total

1.  Comparison of Prognosis Between Microscopically Positive and Negative Surgical Margins for Primary Gastrointestinal Stromal Tumors: A Systematic Review and Meta-Analysis.

Authors:  Zhen Liu; Yichunzi Zhang; Han Yin; Xiuzhu Geng; Sishang Li; Jinrong Zhao; Ziyang Zeng; Xin Ye; Jianchun Yu; Fan Feng; Weiming Kang
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.